Prostate Cancer Cell

Discovering the
future of medicine

Wistar Science: Bold. Imaginative. Inspired.

Learn More

Recent Press Releases

View all ›

Wistar Team Receives Prestigious Award from National Clinical Research Forum for DNA-based Zika Research 

Coalition for Epidemic Preparedness Innovations Supports MERS & Lassa Enhanced DNA Vaccine Technology to Expedite Vaccine Development

Top HIV Cure Research Team Refutes Major Recent Results on
How to Identify HIV Persistence

Our Centers

Ashani Weeraratna in lab

Cancer Center

Wistar is a National Cancer Institute Cancer Center in basic research and has held this designation since 1972.
Vials

Vaccine & Immunotherapy Center

Improving health around the globe by creating and advancing vaccines and immunotherapies.

Upcoming events

View all events ›
Olivera J. Finn, Ph.D.
Douglas R. Green, Ph.D.: LC3-associated phagocytosis: Two ancient pathways collide in inflammation, immunity, and aging
Andrea Califano, M.D.: Systematic Elucidation and Pharmacological Targeting of Non-Oncogene Dependencies in Human Malignancies: A New Take on Precision Oncology

125 Years of Discovery

View full timeline ›
Russel Kaufman

Russel Kaufman

During his tenure, which began in 2002, Russel Kaufman, M.D., embarked on strategic planning and faculty recruitment, and fostered collaborations with regional academic and life sciences industry partners. Dr. Kaufman guided the Institute through its $35 million capital campaign, “Building Wistar, Changing the World,” which began in 2010 and supported the building of the Fox Tower and has substantially raised Wistar’s endowments. Dr. Kaufman stepped down as president and CEO in 2015.

View Full Timeline

Accelerating the future

Right now, Wistar Science is making discoveries that will advance human health.

Support Today